Back to all Representative Matters
May 10, 2019

Eve & Co Completes $10.45 Million Special Warrant Bought Deal Private Placement

Richard M. Kimel, Melanie Cole and Sean Green

On May 10, 2019, Eve & Co Incorporated (TSX-V: EVE) completed a bought deal private placement of 20,900,000 special warrants at a price of $0.50 per special warrant for aggregate gross proceeds of $10,450,000. Eve & Co intends to use the net proceeds for greenhouse expansion and for working capital and general corporate purposes. Haywood Securities Inc. acted as underwriter.

Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and cannabis oil. Natural MedCo Ltd. was Canada’s first female founded licensed producer of medicinal marijuana and received its cultivation license from Health Canada in 2016.

Aird & Berlis LLP represented Eve & Co with a team comprised of Richard Kimel, Melanie Cole and Sean Green (Capital Markets).

Richard Kimel
Short Bio

Richard is a creative and results-driven corporate finance lawyer. Both domestically and internationally, Richard brings his business knowledge to th...

Full Bio

Richard M. Kimel

Partner

rkimel@airdberlis.com

T 416.865.3961 T 416.865.3961

Melanie Cole
Short Bio

Whether advising her clients on public and private financings, mergers and acquisitions or corporate commercial matters, Melanie takes a client-first ...

Full Bio

Melanie Cole

Partner

mcole@airdberlis.com

T 416.865.4638 T 416.865.4638

Sean Green
Short Bio

When it comes to complex capital markets transactions, Sean provides clients with the support they need to navigate regulatory requirements and achiev...

Full Bio

Sean Green

Associate

sgreen@airdberlis.com

T 416.865.7736 T 416.865.7736

Areas of Expertise

Capital Markets

Related Industries

Cannabis

Related Representative Matters

Representative Matters
MediPharm Labs Completes $37.8 Million Private Placement Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Aaron Collins Jun 22, 2020 MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cann... MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a private placement with an institutional investor for aggregate gross proceeds of $37,822,500.
Read More
Representative Matters
Champignon Brands Completes $15 Million Bought Deal Private Placement Jeffrey K. Merk, Melanie Cole, Russell J. Sanders and Francesco Gucciardo Jun 11, 2020 Aird & Berlis advised Champignon Brands Inc., a ketamine clinic operator, psychedelic medicine IP... Aird & Berlis advised Champignon Brands Inc., a ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer, in connection with its $15 million bought deal private placement.
Read More
Representative Matters
Allied Properties REIT Completes $300 Million Debt Offering Margaret T. Nelligan, Sherri M. Altshuler, Anne E. Miatello, Melanie Cole, Liam Tracey-Raymont, Russell J. Sanders, Meredith McCann, Michael D. Smith, Neill Kalvin, Zale Skolnik and Barbara Worndl Jun 11, 2020 Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinc... Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto, recently completed a $300 million debt offering of 3.131% series G senior unsecured debentures.
Read More